Clinical trial
Bivalirudin With Prolonged Full Dose Infusion Versus Heparin Alone During: a Multicenter, Randomized, Open-label Trial
NCT03822975 is registered in ClinicalTrials.gov with Shenyang Northern Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Bivalirudin With Prolonged Full Dose Infusion Versus Heparin Alone During: a Multicenter, Randomized, Open-label Trial
- Lead sponsor
- Shenyang Northern Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 14, 2019
- Completion date
- May 6, 2023
- Enrollment
- 6,016 (actual)
- Sites
- 85
Conditions
As the registry lists them; a condition with its own page is linked.